NCT07495072
- Conditions
- BCG-Induced Cystitis, Carcinoma, Cystitis, +15 more
- Locations
-
- Kyung Hee University Hospital Seoul, Dongdaemun-gu, South Korea
Clinical trial condition
Urologic Neoplasms
Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.
2,952 public trials
630 recruiting studies
Urologic Neoplasms trial results
NCT07492628
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +17 more
- Locations
-
- Peking University Shenzhen Hospital Shenzhen, Guangdong, China
NCT07123090
- Conditions
- Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Carcinoma, +19 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT05024214
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +30 more
- Locations
-
- The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
- The Seventh Medical Center of the PLA General Hospital Beijing, Beijing Municipality, China
- Beijing Hospital Beijing, Beijing Municipality, China
- Fujian Medical University Union Hospital Fuzhou, Fujian, China
Recruiting
Cancer Loyalty Card Study 2 (CLOCS-2)
NCT06447064
- Conditions
- Adnexal Diseases, Bladder Cancer, Colon Cancer, +50 more
- Locations
-
- Imperial College Healthcare NHS Trust London, United Kingdom
NCT05733715
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Abramson Cancer Center at University of Pennsylvania Philadelphia, Pennsylvania, United States
Recruiting
EUS-guided RFA for Solid Abdominal Neoplasms
NCT03221335
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Department of Surgery, Prince of Wales Hospital Hong Kong
NCT07397611
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT05037279
- Conditions
- Bladder Cancer, Bladder Cancer Recurrent, Disease Attributes, +18 more
- Locations
-
- Site 05 Vancouver, British Columbia, Canada
- Site 04 Kingston, Ontario, Canada
- Site 01 Toronto, Ontario, Canada
- Site 02 Toronto, Ontario, Canada
NCT06882486
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Cancer, +9 more
- Locations
-
- Institut Paoli-Calmettes Marseille, Institut Paoli-calmettes, France